VERA (Vera Therapeutics) Insider Ownership: 1.34 % (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VERA Vera Therapeutics Inc VERA
34 GF Score
Price $33.68
! 3 Warning Signs
View Full Analysis

What is Vera Therapeutics Insider Ownership?

Vera Therapeutics VERA -1.09% 34 Insider Ownership is 1.34 % as of Sep. 16, 2026. GuruFocus rates VERA with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vera Therapeutics's insider ownership is 1.34%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vera Therapeutics's Institutional Ownership is 108.33%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vera Therapeutics's Float Percentage Of Total Shares Outstanding is 87.86%.

Vera Therapeutics Insider Ownership Historical Data

* Premium members only.

The historical data trend for Vera Therapeutics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vera Therapeutics Insider Ownership Chart

Vera Therapeutics Historical Data

The historical data trend for Vera Therapeutics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Insider Ownership 1.07 1.07 1.07 1.05 0.96 1.25 1.25 1.23 1.16 1.34
VERA
34GF Score
Vera Therapeutics Inc VERA
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vera Therapeutics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 1.34 % mean?
Vera Therapeutics (VERA) has a Insider Ownership of 1.34 % as of Sep. 16, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Vera Therapeutics and its competitors.
Is Vera Therapeutics' Insider Ownership too high?
Vera Therapeutics' current Insider Ownership is 1.34 %. Overall, Vera Therapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Vera Therapeutics' Insider Ownership compare to NKTR and PHVS?
Vera Therapeutics' Insider Ownership of 1.34 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Vera Therapeutics and its competitors. Vera Therapeutics's current Insider Ownership is 1.34 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vera Therapeutics stock overvalued right now?
Vera Therapeutics (VERA) has a current Insider Ownership of 1.34 %. The current Insider Ownership is 1.34 %. Vera Therapeutics' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Vera Therapeutics (VERA), the current Insider Ownership is 1.34 % as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vera Therapeutics Business Description

Address 2000 Sierra Point Parkway, Suite 1200, Brisbane, CA, USA, 94005
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
34GF Score

Get the complete analysis for VERA

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.68
Price